Guided Therapeutics (GTHP) Current Assets (2010 - 2026)

Guided Therapeutics has disclosed Current Assets across 17 years of filings, most recently posting $527000.0 for Q2 2026.

• In Q2 2026, Current Assets fell 35.02% year-over-year to $527000.0; the TTM figure through Jun 2026 stood at $527000.0 (down 35.02% YoY), while the FY2025 annual figure was $605000.0, down 49.46% from the prior year.
• Current Assets came in at $527000.0 for Q2 2026 at Guided Therapeutics, down from $911000.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.5 million in Q3 2022 to a low of $527000.0 in Q2 2026.
• Average Current Assets over 5 years is $1.4 million, with a median of $1.2 million recorded in 2022.
• Year-over-year, Current Assets jumped 162.88% in 2022 and tumbled 54.8% in 2023.
• Over 5 years, Current Assets stood at $3.0 million in 2022, then tumbled by 53.63% to $1.4 million in 2023, then dropped by 14.07% to $1.2 million in 2024, then sank by 49.46% to $605000.0 in 2025, then fell by 12.89% to $527000.0 in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $527000.0 in Q2 2026, $911000.0 in Q1 2026, and $605000.0 in Q4 2025.